Stock Price Quote

NATURAL CAPSULES LTD.

NSE : NATCAPSUQBSE : 524654ISIN CODE : INE936B01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE222.400.95 (+0.43 %)
PREV CLOSE ( ) 221.45
OPEN PRICE ( ) 223.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3538
TODAY'S LOW / HIGH ( )220.90 224.80
52 WK LOW / HIGH ( )163.55 376.9
NSE223.833.01 (+1.36 %)
PREV CLOSE( ) 220.82
OPEN PRICE ( ) 223.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5039
TODAY'S LOW / HIGH( ) 220.50 230.00
52 WK LOW / HIGH ( )164 274.75
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1993
Management Info
C P Rangachar - Chairman Sunil L Mundra - Managing Director
Registered Office

Address Trident Towers,4th Floor, No. 23, 100 Feet Road,Jaynagar I I Block,
Bengaluru,
Karnataka-560011

Phone 080- 26561562 / 1571 / 1573 / 581

Email info@naturalcapsules.com / company.sec@naturalcapsules.com

Website www.naturalcapsules.com

Registrars Details
Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE, NSE

NEWS

11Jun Natural Capsules informs about earning
Natural Capsules has informed that it enclosed a copy of Transcript of c..
30May Natural Capsules informs about secreta
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosu..
04Jul Natural Capsules informs about press r
Natural Capsules has informed that it enclosed copies of the Newspaper p..
27Jun Natural Capsules informs about closure
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015..
20May Natural Capsules informs about investo
Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Ob..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit26.2667.1199999999999
Gross Profit 31.32 92.9699999999999
Operating Profit 65.99235.36
Net Sales 443.611679.38

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  34611.10 (0.76%)
M.Cap ( in Cr)73055.10
Glenmark Pharma (BSE)
peergroup  1905.15 (4.80%)
M.Cap ( in Cr)53296.44
NGL Fine-Chem (BSE)
peergroup  1325.00 (4.33%)
M.Cap ( in Cr)774.11
Emcure Pharma (BSE)
peergroup  1283.55 (2.18%)
M.Cap ( in Cr)24332.87
Kwality Pharma (BSE)
peergroup  1167.55 (2.08%)
M.Cap ( in Cr)1198.45

Shareholding Pattern

PROMOTERS 51.21%
NON-INSTITUTION 48.79%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Natural Capsules Ltd.

Natural Capsules Ltd. was incorporated in the year 1993. Its today's share price is 222.4. Its current market capitalisation stands at Rs 229.42 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1538.06 Cr and Total Income of Rs.1580.79 Cr. The company's management includes TY Prabhu, Jyoti Mundra, Sushil Kumar Mundra, Pramod Kasat, S G Belapure, Sunil L Mundra, Satyanarayan Mundra, Laxminarayan Moondra, C P Rangachar.

It is listed on the BSE with a BSE Code of 524654 , NSE with an NSE Symbol of NATCAPSUQ and ISIN of INE936B01015. It's Registered office is at Trident Towers,4th Floor, No. 23, 100 Feet Road,Jaynagar I I BlockBengaluru-560011, Karnataka. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Gnanoba & Bhat, P Chandrasekar LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.